Le code SH/NC 293790 est hors champ d'application pour la préparation RDUE.
Hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10) Le moteur de champ d'application indexé renvoie Out of scope pour ce code. No Annex I scope match was found for this indexed CN code.
Pourquoi cette page de référence donne cette réponse.
- Description du code
- Hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10)
- Base annexe I
- Aucune entrée directe à l'annexe I
- Base de la source
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Lignes parentes, filles et voisines.
La vue bibliothèque sert à la navigation de référence. Utilisez le vérificateur lorsque vous voulez lancer un autre code comme action.
29produits chimiques organiquesnarrower2937hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof "incl. chain modified polypeptides", used primarily as hormonesout29379000hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10)(2012-2500);hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives)(2002-2011)out293710pituitary "anterior" or similar hormones, and derivatives, used primarily as hormonesout293711somatropin, its derivatives and structural analogues, used primarily as hormonesout293712insulin and its salts, used primarily as hormonesout293719polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)out293721cortisone, hydrocortisone, prednisone "dehydrocortisone" and prednisolone "dehydrohydrocortisone"out293722halogenated derivatives of corticosteroidal hormonesout
Ce que cela signifie pour la préparation.
Cette ligne ne déclenche pas directement de collecte de preuves dans le résultat de champ d'application actuel.
Regulation (EU) 2023/1115 Annex I — relevant productsconsulté le 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115consulté le 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)consulté le 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)consulté le 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8consulté le 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkingconsulté le 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradersconsulté le 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)consulté le 2026-08-08